236 related articles for article (PubMed ID: 16499817)
1. Diagnostic and prognostic yield of tumor markers in cancer of unknown primary site.
Parvez T; Ibraheim MI
J Coll Physicians Surg Pak; 2006 Feb; 16(2):154-6. PubMed ID: 16499817
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers in metastatic disease from cancer of unknown primary origin.
Milović M; Popov I; Jelić S
Med Sci Monit; 2002 Feb; 8(2):MT25-30. PubMed ID: 11859288
[TBL] [Abstract][Full Text] [Related]
3. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
4. Serum tumor markers in skeletal metastasis.
Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
[TBL] [Abstract][Full Text] [Related]
5. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.
Dennis JL; Hvidsten TR; Wit EC; Komorowski J; Bell AK; Downie I; Mooney J; Verbeke C; Bellamy C; Keith WN; Oien KA
Clin Cancer Res; 2005 May; 11(10):3766-72. PubMed ID: 15897574
[TBL] [Abstract][Full Text] [Related]
6. A case with widespread cutaneous metastases of unknown primary origin: grave prognostic finding in cancer.
Koca R; Ustundag Y; Kargi E; Numanoglu G; Altinyazar HC
Dermatol Online J; 2005 Mar; 11(1):16. PubMed ID: 15748557
[TBL] [Abstract][Full Text] [Related]
7. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic difficulties in diffuse pulmonary infiltrations].
Zielińska-Leś I; Kamiński J; Kozielski J
Wiad Lek; 2006; 59(9-10):724-6. PubMed ID: 17338139
[TBL] [Abstract][Full Text] [Related]
9. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the diagnosis of unknown primary neoplasms].
Nicolosi A; Massidda B; Rais M; Addis E; Tarquini A
Minerva Chir; 1990 Nov; 45(21-22):1343-6. PubMed ID: 2097558
[TBL] [Abstract][Full Text] [Related]
11. [Mediastinal lymph node carcinoma of unknown primary site; report of a case].
Miura K; Yoshizawa K; Tamaki M; Okumura K; Furukita Y
Kyobu Geka; 2009 Mar; 62(3):255-7. PubMed ID: 19280962
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of bone marrow biopsy for bone marrow metastatic tumor with unknown primary tumor site].
Wu Y; Yao LQ; Cheng J; Tian H
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1069-71. PubMed ID: 20501396
[TBL] [Abstract][Full Text] [Related]
13. Total procollagen type 1 amino-terminal propeptide (total P1NP) as a bone metastasis marker in gynecological carcinomas.
Oremek G; Sauer-Eppel H; Klepzig M
Anticancer Res; 2007; 27(4A):1961-2. PubMed ID: 17649805
[TBL] [Abstract][Full Text] [Related]
14. [Unknown primary tumour--diagnostic strategies and treatment].
Møller AK; Gundgaard MG; Petersen BL; Daugaard G
Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and treatment in metastatic adenocarcinoma of unknown primary tumour.
Taal BG; Veenhof CH; Blijham GH; Neijt JP
Neth J Med; 1988 Apr; 32(3-4):204-11. PubMed ID: 3283582
[No Abstract] [Full Text] [Related]
16. Diagnostic strategies for unknown primary cancer.
Varadhachary GR; Abbruzzese JL; Lenzi R
Cancer; 2004 May; 100(9):1776-85. PubMed ID: 15112256
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
18. [Pathological fracture of the ala of the ilium as the form of presentation of an adenocarcinoma of unknown origin].
Iglesias D; Alegre J; Jufresa J; Fernández de Sevilla T
An Med Interna; 1999 Jan; 16(1):55. PubMed ID: 10089663
[No Abstract] [Full Text] [Related]
19. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
Int J Urol; 2006 Sep; 13(9):1197-201. PubMed ID: 16984552
[TBL] [Abstract][Full Text] [Related]
20. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
